4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Thrombopenia in 2 studies
4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd
Excerpt | Relevance | Reference |
---|---|---|
"Hereditary thrombocytopenia is a heterogeneous group of congenital disorders with a wide range of symptoms depending on the severity of platelet dysfunction or thrombocytopenia." | 1.72 | Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. ( Jeong, DJ; Kim, MJ; Kwon, S; Kwon, SR; Lee, DS; Lee, YE; Park, JH; Yun, J, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kwon, SR | 1 |
Kim, MJ | 1 |
Lee, YE | 1 |
Yun, J | 1 |
Jeong, DJ | 1 |
Park, JH | 1 |
Kwon, S | 1 |
Lee, DS | 1 |
Cornish, N | 1 |
Aungraheeta, MR | 1 |
FitzGibbon, L | 1 |
Burley, K | 1 |
Alibhai, D | 1 |
Collins, J | 1 |
Greene, D | 1 |
Downes, K | 1 |
Westbury, SK | 1 |
Turro, E | 1 |
Mumford, AD | 1 |
2 other studies available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Thrombopenia
Article | Year |
---|---|
Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm.
Topics: Disease Susceptibility; Humans; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; | 2022 |
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.
Topics: Humans; Isoxazoles; Thrombocytopenia; Thrombopoietin | 2020 |